Clinical Trial

Genetic Markers Associated With Capsaicinoid Supplementation Effects in Overweight and Obesity

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Capsaicinoids, compounds found in chili peppers of the genus Capsicum, are responsible for their spiciness and may have potential benefits in weight control and cardiometabolic health. They act on processes such as appetite regulation, fat burning, inflammation, and metabolism, although their effects vary among individuals, possibly due to genetic factors. In Mexico, where chili consumption is high and obesity is a significant public health problem, it is particularly relevant to study these genetic variations. The proposed research aims to identify genetic markers that can predict the response to capsaicinoid supplementation and thus develop personalized nutritional strategies for the treatment of obesity and its complications.
Trial Details
NCT Number NCT07602361
Lead Sponsor Universidad Autonoma de Baja California
Conditions Overweight and Obesity
Enrollment 100 participants
Start Date 2026-04-22
Primary Completion 2026-08-26 (estimated)
Study Completion 2026-11-23 (estimated)
Updated on ClinicalTrials.gov 2026-05-22